Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 104 results found. Search for [ essential drugs ]

Results 60 to 80 of 104
New Delhi/Mumbai, September 19, 2014
Drugmakers, including Cipla, Ranbaxy Laboratories, and Cadila Healthcare are among the companies that will be affected by the latest decision.
September 18, 2014
Not all Indian bulk drug makers are reeling before the Chinese onslaught. Some have honed their processes to become world leaders in niche areas.
New Delhi, August 12, 2014
Net sales of the company increased 2.84 per cent to Rs 654.96 crore for the second quarter as compared to Rs 636.86 crore in the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
New Delhi, July 24, 2014
The pricing anomaly has been caught by National Pharmaceutical Pricing Authority which has filed 22 cases this year alone, sending out demand notices that add up to Rs 221.78 crore.
July 15, 2014
\"By issuing a price control order under Para 19 without any consultation with the industry bodies, the NPPA has shocked and disappointed the pharma industry,\" said Shailesh Ayyangar, Managing Director India and Vice-President (South Asia), Sanofi India Limited, one of the companies likely to be affected by this move.
July 14, 2014
India last year raised the number of drugs that are subject to price controls to cover up to 30 per cent of the total medication sold in the country, according to industry officials.
New Delhi, July 5, 2014
Over a period of time, Indian players have steadily migrated up the value chain to focus on value-added formulations with higher margins. As a result, India is today severely dependent on imports for many essential and large-volume drugs, it said.
July 5, 2014
In its latest July 2014 report on the Indian Pharmaceutical industry, the Associated Chambers of Commerce & Industry of India (Assocham) urges the government to \"promote the setting up of vertically integrated manufacturing facilities for essential drugs, at a competitive scale.\"
July 2, 2014
Given the optimistic mood in the country about the reform process, Satish Reddy, President of the Indian Pharmaceutical Alliance (IPA) and Chairman at Dr Reddy's Labs, said that \"the industry will be looking for signals of revival of the growth story\".
Mumbai, June 24, 2014
The move, if implemented, will draw the ire of global drugmakers like Pfizer Inc, GlaxoSmithKline Plc and Abbott Laboratories, all of which have a large presence in India's $15 billion pharmaceutical industry.
May 26, 2014
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon on the five issues that need to be addressed in pharmaceuticals by the new Narendra Modi government:
May 8, 2014
Glenmark Generics Inc., US registered revenue from sale of finished dosage formulations of Rs 5,008.52 million ($81.09 million) for the quarter ended Mar 31, 2014 against revenue of Rs. 4,291.36 million ($79.05 Mn) for the previous corresponding quarter, recording an increase of 16.71 per cent.
New Delhi, May 5, 2014
Cipla chairman Yusuf Hamied, who has long battled global pharmaceutical majors to ensure that developing countries have access to life-saving drugs, has said that a pricecontrol mechanism is required in India for essential medicines sold under a monopoly.
New Delhi, May 3, 2014
\"India is not just contributing to the arena of medicines but also playing a humanitarian role by manufacturing medicines and supplying them at a low cost across the world,\" Hamied said.
February 11, 2014
In an exclusive interview with Business Today, Margaret Hamburg says companies must instill and maintain quality practices so they remain compliant with the FDA's requirements. This commitment to quality manufacturing must be accepted by everyone involved - from top CEOs to the foremen to line workers.
January 29, 2014
No doubt the growth of the Indian pharma industry will continue to be in double digits, but it is also becoming difficult for domestic companies to survive in the current scenario, writes WNS Global Services' Deepak Wadhwa.
February 6, 2014
Stocks of pharmaceutical companies had a stellar run in 2013. The trend is likely to continue. According to the India Brand Equity Foundation, the main drivers for the industry will be outsourcing and investments by MNCs, spread of health insurance and improved health-care facilities.

E Kumar Sharma
December 30, 2013
The Indian pharmaceutical industry faces a crucial new year. Until now, the local industry has largely followed a growth model that focused on launching cheap generic versions of branded innovator drugs made by global pharmaceutical companies.
New Delhi, November 14, 2013
Anti-diabetes medicines is one of the fastest growing medicine segments today, according to AIOCD Pharmasofttech AWACS, a pharma market research company.
New Delhi, October 29, 2013
Net sales of the company rose to Rs 2,750.17 crore during the third quarter, compared to Rs 2,668.52 crore in the same period of the previous year.

PAGES 4 OF 6  12345